Is Invesco Biotechnology & Genome ETF halal to invest in?

As of September 2026, Invesco Biotechnology & Genome ETF PBE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Invesco Biotechnology & Genome ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Invesco Biotechnology & Genome ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for Invesco Biotechnology & Genome ETF updated?

The Shariah compliance status of Invesco Biotechnology & Genome ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like Invesco Biotechnology & Genome ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of Invesco Biotechnology & Genome ETF?

You can check the latest Shariah compliance status of Invesco Biotechnology & Genome ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

Invesco Biotechnology & Genome ETF PBE

PBE Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, Invesco Biotechnology & Genome ETF is classified as halal.

HALAL

Is Invesco Biotechnology & Genome ETF Halal?

Shariah Compliance Analysis of PBE ETF

US Equity Health Care

Yes. As of September 2026, Invesco Biotechnology & Genome ETF (PBE) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Invesco Biotechnology & Genome ETF passes Musaffa's business and financial screening criteria.

PBE was created on 2005-06-23 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 261.65m in AUM and 32 holdings. PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.

Invesco Biotechnology & Genome ETF (PBE) Chart

Key Statistics of Invesco Biotechnology & Genome ETF (PBE)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
99.99%

FAQ's for Invesco Biotechnology & Genome ETF (PBE)

As of September 2026, Invesco Biotechnology & Genome ETF PBE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Invesco Biotechnology & Genome ETF using these criteria to determine its compliance status.
The Shariah compliance status of Invesco Biotechnology & Genome ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Invesco Biotechnology & Genome ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.